Crosstalk between adrenergic and toll-like receptors in human mesenchymal stem cells and keratinocytes

A recipe for impaired wound healing

Mohan R. Dasu, Sandra R. Ramirez, Thi Dinh La, Farzam Gorouhi, Chuong Nguyen, Benjamin R. Lin, Chelcy Mashburn, Heather Stewart, Thomas R. Peavy, Jan Nolta, Roslyn Rivkah Isseroff

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Previous studies demonstrate that skin wounds generate epinephrine (EPI) that can activate local adrenergic receptors (ARs), impairing healing. Bacterially derived activators of Toll-like receptors (TLRs) within the wound initiate inflammatory responses and can also impair healing. In this study, we examined the hypothesis that these two pathways crosstalk to one another, using EPI and macrophage-activating lipopeptide-2 (MALP2) to activate ARs and TLR2, respectively, in human bone marrow-derived mesenchymal stem cells (BM-MSCs) and neonatal keratinocytes (NHKs). BM-MSCs exposed to EPI significantly (p <.05) increased TLR2 message (sevenfold BM-MSCs), TLR2 protein (twofold), and myeloid differentiation factor 88 (MyD88) (fourfold). Conversely, activation of TLR2 by MALP2 in these cells increased β2-AR message (twofold in BM-MSCs, 2.7-fold in NHKs), β2-AR protein (2.5-fold), phosphorylation of β-AR-activated kinase (p-BARK, twofold), and induced release of EPI from both cell types (twofold). Treating cells with EPI and MALP2 together, as would be encountered in a wound, increased β2-AR and p-BARK protein expression (sixfold), impaired cell migration (BM-MSCs- 21%↓ and NHKs- 60%↓, p <.002), and resulted in a 10-fold (BM-MSCs) and 51-fold (NHKs) increase in release of IL-6 (p <.001) responses that were remarkably reduced by pretreatment with β2-AR antagonists. In vivo, EPI-stressed animals exhibited impaired healing, with elevated levels of TLR2, MyD88, and IL-6 in the wounds (p <.05) relative to nonstressed controls. Thus, our data describe a recipe for decreasing cell migration and exacerbating inflammation via novel crosstalk between the adrenergic and Toll-like receptor pathways in BM-MSCs and NHKs.

Original languageEnglish (US)
Pages (from-to)745-759
Number of pages15
JournalStem cells translational medicine
Volume3
Issue number6
DOIs
StatePublished - 2014

Fingerprint

Toll-Like Receptors
Mesenchymal Stromal Cells
Keratinocytes
Adrenergic Agents
Wound Healing
Adrenergic Receptors
Epinephrine
Bone Marrow
Lipopeptides
Myeloid Differentiation Factor 88
Wounds and Injuries
Cell Movement
Interleukin-6
Macrophages
Proteins
Adrenergic Antagonists
Macrophage Activation
Phosphotransferases
Phosphorylation
Inflammation

Keywords

  • Cell migration
  • Cell signaling
  • Mesenchymal stem cells
  • Stem cell-microenvironment interactions
  • Tissue regeneration

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology

Cite this

Crosstalk between adrenergic and toll-like receptors in human mesenchymal stem cells and keratinocytes : A recipe for impaired wound healing. / Dasu, Mohan R.; Ramirez, Sandra R.; La, Thi Dinh; Gorouhi, Farzam; Nguyen, Chuong; Lin, Benjamin R.; Mashburn, Chelcy; Stewart, Heather; Peavy, Thomas R.; Nolta, Jan; Isseroff, Roslyn Rivkah.

In: Stem cells translational medicine, Vol. 3, No. 6, 2014, p. 745-759.

Research output: Contribution to journalArticle

Dasu, Mohan R. ; Ramirez, Sandra R. ; La, Thi Dinh ; Gorouhi, Farzam ; Nguyen, Chuong ; Lin, Benjamin R. ; Mashburn, Chelcy ; Stewart, Heather ; Peavy, Thomas R. ; Nolta, Jan ; Isseroff, Roslyn Rivkah. / Crosstalk between adrenergic and toll-like receptors in human mesenchymal stem cells and keratinocytes : A recipe for impaired wound healing. In: Stem cells translational medicine. 2014 ; Vol. 3, No. 6. pp. 745-759.
@article{c31520fd2c5b429aae93ef25788af3d6,
title = "Crosstalk between adrenergic and toll-like receptors in human mesenchymal stem cells and keratinocytes: A recipe for impaired wound healing",
abstract = "Previous studies demonstrate that skin wounds generate epinephrine (EPI) that can activate local adrenergic receptors (ARs), impairing healing. Bacterially derived activators of Toll-like receptors (TLRs) within the wound initiate inflammatory responses and can also impair healing. In this study, we examined the hypothesis that these two pathways crosstalk to one another, using EPI and macrophage-activating lipopeptide-2 (MALP2) to activate ARs and TLR2, respectively, in human bone marrow-derived mesenchymal stem cells (BM-MSCs) and neonatal keratinocytes (NHKs). BM-MSCs exposed to EPI significantly (p <.05) increased TLR2 message (sevenfold BM-MSCs), TLR2 protein (twofold), and myeloid differentiation factor 88 (MyD88) (fourfold). Conversely, activation of TLR2 by MALP2 in these cells increased β2-AR message (twofold in BM-MSCs, 2.7-fold in NHKs), β2-AR protein (2.5-fold), phosphorylation of β-AR-activated kinase (p-BARK, twofold), and induced release of EPI from both cell types (twofold). Treating cells with EPI and MALP2 together, as would be encountered in a wound, increased β2-AR and p-BARK protein expression (sixfold), impaired cell migration (BM-MSCs- 21{\%}↓ and NHKs- 60{\%}↓, p <.002), and resulted in a 10-fold (BM-MSCs) and 51-fold (NHKs) increase in release of IL-6 (p <.001) responses that were remarkably reduced by pretreatment with β2-AR antagonists. In vivo, EPI-stressed animals exhibited impaired healing, with elevated levels of TLR2, MyD88, and IL-6 in the wounds (p <.05) relative to nonstressed controls. Thus, our data describe a recipe for decreasing cell migration and exacerbating inflammation via novel crosstalk between the adrenergic and Toll-like receptor pathways in BM-MSCs and NHKs.",
keywords = "Cell migration, Cell signaling, Mesenchymal stem cells, Stem cell-microenvironment interactions, Tissue regeneration",
author = "Dasu, {Mohan R.} and Ramirez, {Sandra R.} and La, {Thi Dinh} and Farzam Gorouhi and Chuong Nguyen and Lin, {Benjamin R.} and Chelcy Mashburn and Heather Stewart and Peavy, {Thomas R.} and Jan Nolta and Isseroff, {Roslyn Rivkah}",
year = "2014",
doi = "10.5966/sctm.2013-0200",
language = "English (US)",
volume = "3",
pages = "745--759",
journal = "Stem cells translational medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "6",

}

TY - JOUR

T1 - Crosstalk between adrenergic and toll-like receptors in human mesenchymal stem cells and keratinocytes

T2 - A recipe for impaired wound healing

AU - Dasu, Mohan R.

AU - Ramirez, Sandra R.

AU - La, Thi Dinh

AU - Gorouhi, Farzam

AU - Nguyen, Chuong

AU - Lin, Benjamin R.

AU - Mashburn, Chelcy

AU - Stewart, Heather

AU - Peavy, Thomas R.

AU - Nolta, Jan

AU - Isseroff, Roslyn Rivkah

PY - 2014

Y1 - 2014

N2 - Previous studies demonstrate that skin wounds generate epinephrine (EPI) that can activate local adrenergic receptors (ARs), impairing healing. Bacterially derived activators of Toll-like receptors (TLRs) within the wound initiate inflammatory responses and can also impair healing. In this study, we examined the hypothesis that these two pathways crosstalk to one another, using EPI and macrophage-activating lipopeptide-2 (MALP2) to activate ARs and TLR2, respectively, in human bone marrow-derived mesenchymal stem cells (BM-MSCs) and neonatal keratinocytes (NHKs). BM-MSCs exposed to EPI significantly (p <.05) increased TLR2 message (sevenfold BM-MSCs), TLR2 protein (twofold), and myeloid differentiation factor 88 (MyD88) (fourfold). Conversely, activation of TLR2 by MALP2 in these cells increased β2-AR message (twofold in BM-MSCs, 2.7-fold in NHKs), β2-AR protein (2.5-fold), phosphorylation of β-AR-activated kinase (p-BARK, twofold), and induced release of EPI from both cell types (twofold). Treating cells with EPI and MALP2 together, as would be encountered in a wound, increased β2-AR and p-BARK protein expression (sixfold), impaired cell migration (BM-MSCs- 21%↓ and NHKs- 60%↓, p <.002), and resulted in a 10-fold (BM-MSCs) and 51-fold (NHKs) increase in release of IL-6 (p <.001) responses that were remarkably reduced by pretreatment with β2-AR antagonists. In vivo, EPI-stressed animals exhibited impaired healing, with elevated levels of TLR2, MyD88, and IL-6 in the wounds (p <.05) relative to nonstressed controls. Thus, our data describe a recipe for decreasing cell migration and exacerbating inflammation via novel crosstalk between the adrenergic and Toll-like receptor pathways in BM-MSCs and NHKs.

AB - Previous studies demonstrate that skin wounds generate epinephrine (EPI) that can activate local adrenergic receptors (ARs), impairing healing. Bacterially derived activators of Toll-like receptors (TLRs) within the wound initiate inflammatory responses and can also impair healing. In this study, we examined the hypothesis that these two pathways crosstalk to one another, using EPI and macrophage-activating lipopeptide-2 (MALP2) to activate ARs and TLR2, respectively, in human bone marrow-derived mesenchymal stem cells (BM-MSCs) and neonatal keratinocytes (NHKs). BM-MSCs exposed to EPI significantly (p <.05) increased TLR2 message (sevenfold BM-MSCs), TLR2 protein (twofold), and myeloid differentiation factor 88 (MyD88) (fourfold). Conversely, activation of TLR2 by MALP2 in these cells increased β2-AR message (twofold in BM-MSCs, 2.7-fold in NHKs), β2-AR protein (2.5-fold), phosphorylation of β-AR-activated kinase (p-BARK, twofold), and induced release of EPI from both cell types (twofold). Treating cells with EPI and MALP2 together, as would be encountered in a wound, increased β2-AR and p-BARK protein expression (sixfold), impaired cell migration (BM-MSCs- 21%↓ and NHKs- 60%↓, p <.002), and resulted in a 10-fold (BM-MSCs) and 51-fold (NHKs) increase in release of IL-6 (p <.001) responses that were remarkably reduced by pretreatment with β2-AR antagonists. In vivo, EPI-stressed animals exhibited impaired healing, with elevated levels of TLR2, MyD88, and IL-6 in the wounds (p <.05) relative to nonstressed controls. Thus, our data describe a recipe for decreasing cell migration and exacerbating inflammation via novel crosstalk between the adrenergic and Toll-like receptor pathways in BM-MSCs and NHKs.

KW - Cell migration

KW - Cell signaling

KW - Mesenchymal stem cells

KW - Stem cell-microenvironment interactions

KW - Tissue regeneration

UR - http://www.scopus.com/inward/record.url?scp=84901771685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901771685&partnerID=8YFLogxK

U2 - 10.5966/sctm.2013-0200

DO - 10.5966/sctm.2013-0200

M3 - Article

VL - 3

SP - 745

EP - 759

JO - Stem cells translational medicine

JF - Stem cells translational medicine

SN - 2157-6564

IS - 6

ER -